Submitted by Anonymous (not verified) on 24 October 2024 - 15:00
Pharmacovigilance Risk Assessment Committee (PRAC): 26 - 29 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 26 October 2026 to 29 October 2026
Source: